[Professional risk: hepatitis B. Vaccination strategies in a general hospital].

Acta Gastroenterol Latinoam

Hospital General de Agudos C. Argerich, Unidad Clinica Médica A, Hepatologia, Buenos Aires, Argentina.

Published: April 1993

AI Article Synopsis

Article Abstract

The risk of contracting hepatitis B: (HBV) by health workers is widely accepted. In 1989 our Hepatology Service started a voluntary anti-HBV vaccination program, employing recombinant vaccine (SKF) by intramuscular route with a 0-1-6 month schedule after screening with antibody against the anti-core HBV antigen (AntiHBc Elisa Abbott). Initially, it was planned to monitor antibody titers against superficial antigen (Anti-HBs) 30 days after the last dose. An epidemiological form listing personal data, working area, profession, seniority, written consent for blood extraction and tentative acceptance of vaccination, was completed by 357 hospital staff members. After serological screening, only 184 (51%) workers agreed to receive vaccination. Given the paucity of volunteers, an attempt was made to explain this degree of reluctance by a randomized blind voluntary survey, to which 349 hospital staff members and 40 medical students replied. Questions were related to knowledge concerning vaccination in general, hepatitis and particularly hepatitis B, and specific anti-HBV vaccination. An appraisal of data gathered disclosed a considerable lack of information not only on the risk of HBV infection and its complications, but also on the existence of a suitable vaccine. Non-existent adverse effects of vaccination were mentioned, including AIDS (Acquired Immuno-Deficiency Syndrome), hepatitis and cirrhosis, among others. To overcome this obstacle, we held a two-day workshop on hepatitis B prevention and prophylaxis intended for medical and ancillary staff. After the meeting, which were attended by 221 members, 48 individuals, comprising 25 physicians and 23 nurses, spontaneously requested to be vaccinated.(ABSTRACT TRUNCATED AT 250 WORDS)

Download full-text PDF

Source

Publication Analysis

Top Keywords

anti-hbv vaccination
8
hospital staff
8
staff members
8
vaccination
7
hepatitis
6
[professional risk
4
risk hepatitis
4
hepatitis vaccination
4
vaccination strategies
4
strategies general
4

Similar Publications

Article Synopsis
  • The study assessed the effectiveness of a booster HBV vaccine in Italian medical students, revealing that a significant portion had low antibody levels after 15 years.
  • Out of 625 students, 355 were given a booster, and 92.77% of those who received it achieved adequate antibody levels after one month.
  • Results showed that physical activity improved immune response to the booster, highlighting the importance of maintaining higher pre-booster antibody levels for better vaccine effectiveness.
View Article and Find Full Text PDF

Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA.

Genes Dis

January 2025

The Key Laboratory of Molecular Biology of Infectious Diseases Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400000, China.

Human hepatitis B virus (HBV) infection is the major cause of acute and chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma. Although the application of prophylactic vaccination programs has successfully prevented the trend of increasing HBV infection prevalence, the number of HBV-infected people remains very high. Approved therapeutic management efficiently suppresses viral replication; however, HBV infection is rarely completely resolved.

View Article and Find Full Text PDF

Hepatitis B virus in oocytes and embryos: pregnancy outcomes and children's health.

F S Rep

September 2024

Department of Reproductive Endocrinology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.

Objective: To investigate whether the presence of hepatitis B virus (HBV) in oocytes and embryos affects pregnancy outcomes for in vitro fertilization and embryo transfer (ET) as well as is related to the vertical transmission of HBV to children.

Design: Retrospective cohort study.

Setting: A university-affiliated fertility center.

View Article and Find Full Text PDF
Article Synopsis
  • Healthcare workers are at a high risk for hepatitis B virus (HBV) infection, making vaccination and antibody level monitoring essential after immunization.
  • A study conducted on 200 healthcare workers in Šabac, Serbia found that while 100% were vaccinated, only 85% had a protective antibody level, indicating a gap in vaccine effectiveness.
  • Factors influencing antibody levels included the number of vaccine doses received and pre-existing health conditions, highlighting the need for improved monitoring strategies and continuous education for healthcare professionals regarding vaccination safety.
View Article and Find Full Text PDF

Unlabelled: A cell culture system that allows the reproduction of the hepatitis B virus (HBV) life cycle is indispensable to exploring novel anti-HBV agents. To establish the screening system for anti-HBV agents, we exploited the high affinity and bright luminescence (HiBiT) tag and comprehensively explored the regions in the HBV genome where the HiBiT tag could be inserted. The plasmids for the HiBiT-tagged HBV molecular clones with a 1.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!